Klaus P Ebmeier Selected Research

Schizophrenia (Dementia Praecox)

5/2014	Improving the detection and treatment of schizophrenia.
9/2006	Functional imaging as a predictor of schizophrenia.
1/2006	Transcranial magnetic stimulation for schizophrenia.
6/2004	Transcranial magnetic stimulation for auditory hallucinations in schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Klaus P Ebmeier Research Topics

Disease

13	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 07/2004
8	Dementia (Dementias) 01/2021 - 11/2010
6	Cognitive Dysfunction 01/2022 - 01/2010
4	Schizophrenia (Dementia Praecox) 05/2014 - 06/2004
3	Major Depressive Disorder (Major Depressive Disorders) 10/2015 - 08/2008
2	Hypertension (High Blood Pressure) 01/2021 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
2	Stroke (Strokes) 01/2017 - 08/2012
2	Coronary Disease (Coronary Heart Disease) 01/2017 - 08/2012
2	Depressive Disorder (Melancholia) 04/2016 - 05/2014
2	Disease Progression 09/2014 - 05/2011
2	Hallucinations (Hallucination) 01/2011 - 06/2004
2	Mood Disorders (Mood Disorder) 01/2011 - 11/2009
1	Alcoholism (Alcohol Abuse) 01/2022
1	Sleep Deprivation 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Abdominal Obesity 01/2017
1	Necrosis 10/2015
1	Hypothyroidism 05/2014
1	Parkinsonian Disorders (Parkinsonism) 02/2013
1	Vascular Diseases (Vascular Disease) 08/2012
1	Vascular Depression 07/2012
1	Diabetes Mellitus 11/2011
1	Hyperglycemia 11/2011
1	Psychotic Disorders (Schizoaffective Disorder) 05/2011
1	Parkinson Disease (Parkinson's Disease) 01/2011
1	Weight Gain 05/2010
1	Type 2 Diabetes Mellitus (MODY) 01/2010
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2010
1	Confusion (Bewilderment) 08/2008
1	Seizures (Absence Seizure) 08/2008

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2010
6	Apolipoproteins E (ApoE)IBA 06/2015 - 01/2010
3	Apolipoprotein E4IBA 01/2021 - 02/2010
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 05/2010
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2013 - 02/2010
2	CholesterolIBA 01/2021 - 01/2019
2	HDL CholesterolIBA 01/2019 - 01/2017
2	LipidsIBA 01/2017 - 05/2010
2	C-Reactive ProteinIBA 04/2016 - 10/2015
2	Folic Acid (Vitamin M)FDA LinkGeneric 05/2014 - 01/2010
2	LigandsIBA 11/2010 - 04/2008
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2010 - 04/2008
2	salicylhydroxamic acid (SHAM)IBA 01/2006 - 06/2004
1	Transferrin (beta 2 Transferrin)IBA 01/2022
1	IronIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 11/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2017
1	HDL LipoproteinsIBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	Protons (Proton)IBA 01/2017
1	CytokinesIBA 04/2016
1	Interleukin-6 (Interleukin 6)IBA 04/2016
1	InterleukinsIBA 10/2015
1	ApolipoproteinsIBA 09/2014
1	Antipsychotic Agents (Antipsychotics)IBA 05/2014
1	Memantine (Namenda)FDA Link 01/2013
1	Rivastigmine (Exelon)FDA LinkGeneric 01/2013
1	Galantamine (Galanthamine)FDA LinkGeneric 01/2013
1	Donepezil (Aricept)FDA LinkGeneric 01/2013
1	Indicators and Reagents (Reagents)IBA 08/2012
1	GlucocorticoidsIBA 07/2012
1	Antidepressive Agents (Antidepressants)IBA 11/2011
1	antineoplaston A10 (A 10)IBA 05/2011
1	Levodopa (L Dopa)FDA LinkGeneric 01/2011
1	Cholinergic Agents (Cholinergics)IBA 11/2010
1	Amyloid beta-PeptidesIBA 02/2010
1	Genetic Markers (Genetic Marker)IBA 02/2010
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2010
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2010
1	AntioxidantsIBA 01/2010
1	Dehydroepiandrosterone (DHEA)IBA 01/2010
1	Vitamin B 6IBA 01/2010
1	Procaine (Novocaine)FDA LinkGeneric 01/2010
1	VitaminsIBA 01/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2010
1	ElementsIBA 11/2009
1	Prednisolone (Predate)FDA LinkGeneric 09/2006
1	AminesIBA 07/2004
1	OximesIBA 07/2004

Therapy/Procedure

3	Transcranial Magnetic Stimulation 01/2011 - 06/2004
2	Activities of Daily Living (ADL) 01/2014 - 01/2013
2	Therapeutics 02/2010 - 08/2008
1	Music Therapy 04/2014
1	Massage (Zone Therapy) 04/2014
1	Aromatherapy 04/2014
1	Secondary Prevention 01/2013
1	Hearing Aids (Hearing Aid) 01/2011